including

India struggles with a quit success rate under 5%: Experts back OTC access to NRT across all formats and dosages, including 2 mg and 4 mg

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical to scaling quit outcomes and…

2 weeks ago

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

April 27, 2026 17:00 ET  | Source: Cabaletta Bio PHILADELPHIA, April 27, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq:…

4 weeks ago

Mantle Confirms Full Network Security and Coordinates Recovery With Aave, Including Potential Treasury Participation Following rsETH by KelpDAO Incident

DUBAI, UAE, April 21, 2026 /PRNewswire/ -- Mantle, the premier distribution layer connecting traditional finance and on-chain liquidity, today has…

1 month ago

Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi

TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

1 month ago

Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 One Solution for Complete Mac Disk Access on Windows – Including Native Encrypted APFS Support

WOODSTOCK, Ill., April 18, 2026 (GLOBE NEWSWIRE) -- WOODSTOCK, Ill. and LAS VEGAS (April 18, 2026) Other World Computing (OWC®),…

1 month ago

Arclin Completes Acquisition of the DuPont Aramids Business, Including Iconic Kevlar and Nomex Brands

ALPHARETTA, Ga., April 1, 2026 /PRNewswire/ -- Arclin, a global materials science company, today announced that it has completed the…

2 months ago

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam Repair System and REGENETEN Bioinductive Implant at AAOS 2026

Uniting the most advanced technologies for biomechanical repair and biological augmentation  Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today…

3 months ago

Zealthy ED Platform in 2026 (Including Hardies Sublingual Formulations): Telehealth ED Treatment Options, Compounded Medication Pricing, and What Consumers Should Verify Before Starting

New York, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through…

3 months ago

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

February 20, 2026 15:10 ET  | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eupraxia…

3 months ago

Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai

TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

4 months ago